Protein phosphatase 5 protects neurons against amyloid-β toxicity
Article first published online: 17 AUG 2009
© 2009 The Authors. Journal Compilation © 2009 International Society for Neurochemistry
Journal of Neurochemistry
Volume 111, Issue 2, pages 391–402, October 2009
How to Cite
Sanchez-Ortiz, E., Hahm, B. K., Armstrong, D. L. and Rossie, S. (2009), Protein phosphatase 5 protects neurons against amyloid-β toxicity. Journal of Neurochemistry, 111: 391–402. doi: 10.1111/j.1471-4159.2009.06337.x
- Issue published online: 23 SEP 2009
- Article first published online: 17 AUG 2009
- Received April 22, 2009; revised manuscript received July 20, 2009; accepted July 27, 2009.
- Alzheimer’s disease;
- oxidative stress;
- protein phosphatase 5
Amyloid-β (Aβ) is thought to promote neuronal cell loss in Alzheimer’s disease, in part through the generation of reactive oxygen species (ROS) and subsequent activation of mitogen-activated protein kinase (MAPK) pathways. Protein phosphatase 5 (PP5) is a ubiquitously expressed serine/threonine phosphatase which has been implicated in several cell stress response pathways and shown to inactivate MAPK pathways through key dephosphorylation events. Therefore, we examined whether PP5 protects dissociated embryonic rat cortical neurons in vitro from cell death evoked by Aβ. As predicted, neurons in which PP5 expression was decreased by small-interfering RNA treatment were more susceptible to Aβ toxicity. In contrast, over-expression of PP5, but not the inactive mutant, PP5(H304Q), prevented MAPK phosphorylation and neurotoxicity induced by Aβ. PP5 also prevented cell death caused by direct treatment with H2O2, but did not prevent Aβ-induced production of ROS. Thus, the neuroprotective effect of PP5 requires its phosphatase activity and lies downstream of Aβ-induced generation of ROS. In summary, our data indicate that PP5 plays a pivotal neuroprotective role against cell death induced by Aβ and oxidative stress. Consequently, PP5 might be an effective therapeutic target in Alzheimer’s disease and other neurodegenerative disorders in which oxidative stress is implicated.